by McDermott + Bull | Sep 26, 2026 | Ken Dropiewski, Dani Rone, Ken Dropiewski Placement Announcement
McDermott + Bull has successfully placed Jeffrey DellaFranco as Vice President of Sales at Galvanize Therapeutics. In this role, Jeff will lead the company’s U.S. sales organization and support its transition to a procedure-focused commercial model. He will focus on...
by McDermott + Bull | Sep 22, 2026 | Ken Dropiewski, Ken Dropiewski Placement Announcement, Michael Matranga
McDermott + Bull has successfully placed Rhonda Robb as Chief Executive Officer at ArchCath. In this role, Rhonda will lead the company through its next phase of growth, with responsibility for advancing its financing, clinical, regulatory, and commercialization...
by McDermott + Bull | Aug 11, 2026 | Ken Dropiewski, Ken Dropiewski Placement Announcement, Michael Matranga
McDermott + Bull has successfully placed David Vort as Chief Commercial Officer at Caristo Diagnostics. In this role, David will lead the company’s U.S. commercial strategy, with responsibility for accelerating revenue, advancing market access and reimbursement...
by McDermott + Bull | Jul 8, 2026 | Ken Dropiewski Placement Announcement, Christiana Chan, Ken Dropiewski
McDermott + Bull has successfully placed Chris Wolff as Senior Vice President, Market Development at FIRE1 Medical. In this role, Chris will lead the company’s U.S. market development strategy as FIRE1 advances toward commercialization of its breakthrough heart...
by McDermott + Bull | May 26, 2026 | Placement Announcement, Ken Dropiewski, Ken Dropiewski Placement Announcement
McDermott + Bull has successfully placed Edward Sarnowski as Chief Technology Officer at JenaValve Technology, Inc. Edward will lead the company’s technology and research and development strategy, overseeing the advancement and commercialization of innovative...
by McDermott + Bull | Dec 1, 2025 | Placement Announcement, Brittany Stansfield, Brittany Stansfield Placement Announcement, Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Jennifer Ness, Ken Dropiewski, Ken Dropiewski Placement Announcement, Paul Gibbons, Paul Gibbons Placement Announcement
McDermott + Bull has successfully placed Lisa Downey as Chief Executive Officer at DrugBank. In this role, Lisa will lead the company’s next phase of growth, deepening its impact across pharmaceutical R&D and AI-driven drug discovery while scaling commercial...
